[Federal Register Volume 68, Number 105 (Monday, June 2, 2003)]
[Notices]
[Page 32733]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-13597]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Method of Establishing 
Cultures of Human Dendritic Cells and Use Thereof

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent Application No. 
09/712,688 entitled ``Method of Establishing Cultures of Human 
Dendritic Cells and Use Thereof,'' filed November 14, 1999. Foreign 
rights are also available (PCT/US00/31465). The United States 
Government, as represented by the Secretary of the Army, has rights in 
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
Attn: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: A simple method for producing dendritic 
cells from peripheral blood monocytes is provided. The dendritic cells 
may be used as adjuvants for vaccines and immunotherapies. The mature 
dendritic cells also provide an effective means of producing novel T 
cell dependent antigens comprised of dendritic cell modified antigens 
useful as vaccines or for the treatment of disease.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 03-13597 Filed 5-30-03; 8:45 am]
BILLING CODE 3710-08-M